BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9553657)

  • 1. The changing landscape of breast cancer clinical research. ESMO-Award Lecture, ECCO-9 Hamburg, 18 September 1997.
    Piccart MJ
    Ann Oncol; 1998 Feb; 9(2):133-8. PubMed ID: 9553657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can be expected from the next generation of adjuvant breast cancer treatment?
    Piccart-Gebhart M
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):22-5. PubMed ID: 10203267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine therapy and other targeted therapies for metastatic breast cancer.
    Hussain SA; Palmer DH; Moon S; Rea DW
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC-Breast Cancer Cooperative Group clinical research programme in early breast cancer. EORTC-BCCG.
    Piccart MJ; van de Velde CJ
    Recent Results Cancer Res; 1998; 152():447-52. PubMed ID: 9928579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions to the understanding and management of breast cancer. Steiner Award Lecture 1992.
    Fisher B
    Int J Cancer; 1993 Sep; 55(2):179-80. PubMed ID: 8370613
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Emens LA; Davidson NE
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):486S-94S. PubMed ID: 12538505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Targeted based therapies in metastatic breast cancer: future evolution].
    Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
    Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatment.
    Conte P; Guarneri V; Bengala C
    Clin Breast Cancer; 2007 Dec; 7(11):841-9. PubMed ID: 18269773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the new biology for therapy in breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-negative breast cancer.
    Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
    Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of breast cancer heralds a changing treatment paradigm.
    Ellis M
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):750-2. PubMed ID: 24853210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer management.
    Therasse P; Piccart M; van de Velde CJ; Jassem J;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S39-43. PubMed ID: 11858963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic breast cancer: looking towards the future.
    Amar S; Roy V; Perez EA
    Breast Cancer Res Treat; 2009 Apr; 114(3):413-22. PubMed ID: 18465221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).
    Gori S; Puglisi F; Cinquini M; Pappagallo G; Frassoldati A; Biganzoli L; Cortesi L; Fiorentino A; Angiolini C; Tinterri C; De Censi A; Levaggi A; Del Mastro L
    Eur J Cancer; 2018 Aug; 99():9-19. PubMed ID: 29886394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.